For The Better

The CDC may have sunk the cruise line’s stock today.

KFY earnings call for the period ending July 31, 2021.

Sticking with well-known names can be a smart move.

A leading manufacturer of intravenous therapy solutions is about to get a lot bigger.

Europe is next in line to take a look at the Nvidia-Arm deal.

AFMD earnings call for the period ending June 30, 2021.

CNN sounds the alarm on marijuana’s risks to heart health.

There has been a major shakeup in the C-suite.

The company is seen as a short squeeze target on the popular subreddit WallStreetBets.

Hydrogen fuel cell electric vehicles are gaining attention. That’s both good and bad for Nikola.

Discussing Affirm’s latest partnership announcement and its 44% stock increase.

El Salvador is using Bitcoin as legal tender, but it’s exploring Algorand for other purposes.

The company could soon be airborne again.

A secondary offering spooked investors.

An unexpected regulatory setback weighed heavily on the biotech’s shares last month.

Paylocity reported a great quarter and provided strong forecasts for next year.

The growth stock is having trouble winning over new investors after taking a beating this year.

The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock’s value. And, at some point, people will want to take profits.

A great earnings report sent shares higher as growth stocks charged ahead.

DADA earnings call for the period ending June 30, 2021.